These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 33994484)

  • 1. Clinical markers and some trace elements in patients with type-2 diabetic nephropathy : Impact of insulin resistance.
    Al-Fartosy AJM; Awad NA; Alsalimi SA
    J Med Invest; 2021; 68(1.2):76-84. PubMed ID: 33994484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential serum biomarkers for early detection of diabetic nephropathy.
    Motawi TK; Shehata NI; ElNokeety MM; El-Emady YF
    Diabetes Res Clin Pract; 2018 Feb; 136():150-158. PubMed ID: 29253627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing urinary levels of IL-18, NGAL and albumin creatinine ratio in patients with diabetic nephropathy.
    Sueud T; Hadi NR; Abdulameer R; Jamil DA; Al-Aubaidy HA
    Diabetes Metab Syndr; 2019; 13(1):564-568. PubMed ID: 30641767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utility of urinary biomarkers as a diagnostic tool for early diabetic nephropathy in patients with type 2 diabetes mellitus.
    Vijay S; Hamide A; Senthilkumar GP; Mehalingam V
    Diabetes Metab Syndr; 2018 Sep; 12(5):649-652. PubMed ID: 29673928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of Neutrophil Gelatinase-Associated Lipocalin (NGAL) and Retinol-Binding Protein 4 (RBP4) in Type 2 Diabetic Patients with Nephropathy.
    Mahfouz MH; Assiri AM; Mukhtar MH
    Biomark Insights; 2016; 11():31-40. PubMed ID: 26917947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary tubular biomarkers in short-term type 2 diabetes mellitus patients: a cross-sectional study.
    Fu WJ; Xiong SL; Fang YG; Wen S; Chen ML; Deng RT; Zheng L; Wang SB; Pen LF; Wang Q
    Endocrine; 2012 Feb; 41(1):82-8. PubMed ID: 21779943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of omentin 1 and IL-6 in type 2 diabetes mellitus patients with diabetic nephropathy.
    Senthilkumar GP; Anithalekshmi MS; Yasir M; Parameswaran S; Packirisamy RM; Bobby Z
    Diabetes Metab Syndr; 2018; 12(1):23-26. PubMed ID: 28864059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationships between diabetic nephropathy and insulin resistance, inflammation, Trx, Txnip, CysC and serum complement levels.
    Xu LL; Gao W; Chen ZM; Shao KK; Wang YG; -L Cui L; Guo NZ
    Eur Rev Med Pharmacol Sci; 2020 Nov; 24(22):11700-11706. PubMed ID: 33275238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary biomarkers of tubular injury to predict renal progression and end stage renal disease in type 2 diabetes mellitus with advanced nephropathy: A prospective cohort study.
    Satirapoj B; Pooluea P; Nata N; Supasyndh O
    J Diabetes Complications; 2019 Sep; 33(9):675-681. PubMed ID: 31227289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes of the tubular markers in type 2 diabetes mellitus with glomerular hyperfiltration.
    Fu WJ; Li BL; Wang SB; Chen ML; Deng RT; Ye CQ; Liu L; Fang AJ; Xiong SL; Wen S; Tang HH; Chen ZX; Huang ZH; Peng LF; Zheng L; Wang Q
    Diabetes Res Clin Pract; 2012 Jan; 95(1):105-9. PubMed ID: 22015481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic Accuracy of Neutrophil Gelatinase-Associated Lipocalin for Predicting Early Diabetic Nephropathy in Patients with Type 1 and Type 2 Diabetes Mellitus: A Systematic Review and Meta-analysis.
    Kapoula GV; Kontou PI; Bagos PG
    J Appl Lab Med; 2019 Jul; 4(1):78-94. PubMed ID: 31639710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased serum myonectin concentrations in diabetic nephropathy patients.
    Zhang J; Hu W; Lin P; Wang R
    Clin Exp Med; 2020 Nov; 20(4):601-607. PubMed ID: 32852729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Zinc alpha 2 glycoprotein as an early biomarker of diabetic nephropathy in patients with type 2 diabetes mellitus.
    Elsheikh M; Elhefnawy KA; Emad G; Ismail M; Borai M
    J Bras Nefrol; 2019; 41(4):509-517. PubMed ID: 30897192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxidative stress markers in type 2 diabetes patients with diabetic nephropathy.
    Chou ST; Tseng ST
    Clin Exp Nephrol; 2017 Apr; 21(2):283-292. PubMed ID: 27233502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Profile of Plasma Free Amino Acids in Type 2 Diabetes Mellitus with Insulin Resistance: Association with Microalbuminuria and Macroalbuminuria.
    Saleem T; Dahpy M; Ezzat G; Abdelrahman G; Abdel-Aziz E; Farghaly R
    Appl Biochem Biotechnol; 2019 Jul; 188(3):854-867. PubMed ID: 30706418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Markers of Glomerular and Tubular Damage in the Early Stage of Kidney Disease in Type 2 Diabetic Patients.
    Żyłka A; Dumnicka P; Kuśnierz-Cabala B; Gala-Błądzińska A; Ceranowicz P; Kucharz J; Ząbek-Adamska A; Maziarz B; Drożdż R; Kuźniewski M
    Mediators Inflamm; 2018; 2018():7659243. PubMed ID: 30158836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of Serum Micro-RNA 152-3p in Type 2 Diabetes Mellitus with a Significant Elevation in Progressive Nephropathy.
    Nasser M; Ibrahim KMF; Elnabawi WM; Ahmed TM
    Egypt J Immunol; 2020 Jun; 27(2):81-92. PubMed ID: 33548980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum cystatin C in diabetic patients. Not only an indicator for renal dysfunction in patients with overt nephropathy but also a predictor for cardiovascular events in patients without nephropathy.
    Ogawa Y; Goto T; Tamasawa N; Matsui J; Tando Y; Sugimoto K; Tomotsune K; Kimura M; Yasujima M; Suda T
    Diabetes Res Clin Pract; 2008 Feb; 79(2):357-61. PubMed ID: 17980929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma Neutrophil Gelatinase-Associated Lipocalin as a Marker of Tubular Damage in Diabetic Nephropathy.
    Kim SY; Jeong TD; Lee W; Chun S; Sunwoo S; Kim SB; Min WK
    Ann Lab Med; 2018 Nov; 38(6):524-529. PubMed ID: 30027695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NGAL and cystatin C: two possible early markers of diabetic nephropathy in young patients with type 1 diabetes mellitus: one year follow up.
    Papadopoulou-Marketou N; Skevaki C; Kosteria I; Peppa M; Chrousos GP; Papassotiriou I; Kanaka-Gantenbein C
    Hormones (Athens); 2015; 14(2):232-40. PubMed ID: 25402375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.